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Abstract
The aggregation of α-synuclein (α-syn), a protein implicated in Parkinson’s disease (PD), is believed
to progress through the formation of a partially folded intermediate. Using nano-electrospray
ionization (ESI) mass spectrometry combined with ion mobility measurements we found evidence
for a highly compact partially folded family of structures for α-syn and its disease-related A53T
mutant with net charges of −6, −7 and −8. For the other early-onset PD mutant, A30P, this highly
compact population was only evident when the protein had a net charge of −6. When bound to
spermine near physiologic pH, all three proteins underwent a charge reduction from the favored
solution charge state of −10 to a net charge of −6. This charge reduction is accompanied by a dramatic
size reduction of about a factor of two (cross section of 2600Å2 (−10 charge state) down to
1430Å2 (−6 charge state)). We conclude that spermine increases the aggregation rate of α-syn by
inducing a collapsed conformation, which then proceeds to form aggregates.
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Introduction
α-synuclein (α-syn) is the primary proteinaceous material implicated in the pathogenesis of
Parkinson’s disease (PD). Although the etiology of PD is still unknown, α-syn became the
focus of PD research when it was first discovered as the primary fibrillar component in Lewy
bodies and Lewy neurites found in the brains of PD patients.1 Additionally, rare inherited
autosomal early-onset forms of PD are linked to two missense mutations, A53T and A30P,
found in the gene that codes for α-syn.2,3 In recent years, a growing body of evidence suggests
that oligomeric assemblies of α-syn are responsible for the toxic effects seen in PD and that
the fibrillar deposits are perhaps a byproduct of neuronal death.4–6
α-syn belongs to a family of closely related presynaptic proteins. It is highly soluble and has
140 amino acid residues including seven imperfect repeats near the N-terminal region and a
highly acidic C-terminal region. In vitro studies of α-syn and the A30P and A53T mutants
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show the proteins are natively unfolded, having little or no ordered structure in the soluble
form under physiological conditions.7–9 Small-angle x-ray scattering studies indicate that at
neutral pH these proteins have radii of gyration of about 40Å, larger than expected for a folded
globular protein (15Å), and smaller than predicted for a random coil conformation (52Å).7,
10 Fibrillization is believed to be a byproduct of α-syn misfolding that occurs in a nucleation
dependent mechanism4 initiated by a critical structural transformation from an unfolded
conformation to a partially folded intermediate.7 These studies indicate that α-syn most likely
populates several intermediate conformations, both monomeric and oligomeric, on the pathway
to the mature fibril form.7,11 The rate of aggregation is affected by both the A53T and A30P
mutations. It is generally agreed upon that the A53T mutation increases the rate of aggregation,
4,11–14 but studies on the A30P mutation have been far less conclusive. There are reports of
faster aggregation,13 of similar aggregation rates,14 and of more rapid monomer consumption
but slower fibril formation relative to WT α-syn.4,11,12
Spermine is a naturally occurring polyamine found in neuronal cells15–17 that has, along with
other polyamines, been shown to increase the rate of aggregation and fibrillation of α-syn.18,
19 Although a complete profile of its functions is still unknown, spermine is known to be
involved in neurodegenerative processes.20 At physiological pH, spermine exists as a
polycation and forms a complex with α-syn. This complex formation increases the rate of α-
syn fibrillation without inducing significant secondary structure in this natively unfolded
protein.18,19,21 A recent NMR study demonstrated that although spermine is known to bind
in the highly acidic C-terminal region, the complex 1H-15N HSQC spectrum shows significant
intensity changes in the peaks corresponding to glycine and threonine residues in the N-
terminal region, amino acids 22–93, as compared to the free protein.21 The two mutants
investigated in this study, A30P and A53T, have substitutions in this region and we were
curious to see if these substitutions had a significant effect on the complex structures.
It is critical to pursue methods that give insight into the actual structure of the α-syn monomers
and probe any structural transitions that may occur in order to develop effective therapeutic
strategies. Ion mobility spectroscopy is a powerful method for achieving this goal, allowing
accurate measurement of collision cross sections (shape). In this study we used ion mobility
mass spectrometry to examine the structural features of the A30P and A53T mutant monomers
and spermine complexes in comparison to WT α-syn.
Materials and Methods
Sample Preparation
Spermine was purchased from Sigma (St. Louis, Mo) and used without further purification.
All α-syn samples were purchased from rPeptide (Bogart, Ga). Samples for nano-ESI
experiments were prepared by dissolving the lyophilized proteins in water to make
concentrated stock solutions. pH 7.5 and pH 2.5 solutions were prepared by dialyzing the stock
solutions in 10mM ammonium acetate overnight using Slide-a-lyzer Mini Dialysis Units (3.5K
MWCO, Pierce Biotechnology, Rockford, IL). Samples were then filtered using Microcon
YM-100 Centrifugal Filter Devices (100K MWCO, Millipore Corp., Billerica, MA) to filter
out large aggregates, and adjusted to the desired pH using NH4OH and CH3COOH. The
concentrations were determined from UV absorption using an estimated extinction coefficient
of 5120 M−1cm−1 at 280 nm.22 Solutions were diluted to ~ 5–10 µM concentrations
immediately prior to use. For samples containing spermine, spermine was added after this final
dilution in a 1:10 α-syn to spermine ratio. Samples were left in a refrigerator overnight, to
improve binding, before running.
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Instrumentation
Details of the experimental set up for obtaining mass spectra and ion mobilities have previously
been published elsewhere,23 so only a brief description will be given here. The instrument
consists of a nano electrospray ionization (nano-ESI) source, an ion funnel, a drift cell, and a
quadrupole mass filter. Ions are generated in the source from ~ 5 µL of sample solution
contained in a metal coated borosilicate capillary (Proxeon, Odense, Denmark). A continuous
beam of ions is created and injected into the ion funnel. The ion funnel acts as an interface
between the source and high vacuum chamber and transports the ions to the drift cell without
the use of high acceleration fields. The drift cell is filled with ~ 5 torr of helium buffer gas and
is followed by a quadrupole mass filter and a detector. To obtain mass spectra a continuous
beam of ions passes through the drift cell and quadrupole mass filter before arriving at the
detector.
To obtain mobility data the ion funnel is used as a storage device and the ions are pulsed into
the drift cell triggering a timing sequence. Once the ions enter the cell, they are quickly
thermalized by collisions with the helium buffer gas and are pulled through the drift cell by a
weak electric field, E. Due to the counterbalance of the forward acceleration and the frictional
drag, the ions obtain a constant drift velocity, vD, proportional to E
(1)
where the proportionality constant K is the ion mobility. In the low field limit, K is a function
of the buffer gas pressure, P, the temperature, T, the reduced mass, μ, of the colliding particles
(ion + He), and the ion’s collision cross section, s.
Once the ions exit the drift cell, they pass through the quadrupole mass filter and are detected
as a function of time, producing an arrival time distribution (ATD). Through the use of kinetic
theory, the mobility is related to the collision-cross section, s, as given in equation 2:24
(2)
where z is the charge on the ion, kB is the Boltzmann constant, N is the He number density at
STP, l is the length of the cell, tA is the time it takes the ion to arrive at the detector after the
initial pulse into the drift cell, and t0 is the time it takes the ions to reach the detector after
exiting the drift cell. Since all of the constants in equation (2) are known for a given experiment
and P, T, E, and tA and t0 can be very accurately measured, a precise value of σ is obtained.
The injection energy with which ions enter the drift cell is an important variable. At low
injection energies the ions are gently pushed into the cell and only need a few “cooling”
collisions to reach thermal equilibrium with the buffer gas. At high injection energies the larger
collision energy leads to internal excitation of the ions before cooling and equilibrium occur.
This can lead to isomerization to the most stable gas phase conformations or dissociation of
dimers and higher-order oligomers if they are present. Unless otherwise stated, all mass spectra
and ATDs were taken at an intermediate injection energy value of 40–50eV.
Results
Negative ion mass spectra were collected at pH 2.5 and pH 7.5 for WT α-syn and its A30P and
A53T mutants. Negative ion mode was chosen due to the large number of acidic residues, D
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and E, relative to basic residues, K and R in the amino acid sequence of the proteins (24
compared to 15) resulting in a net negative charge in solution at neutral pH. As all three proteins
produced very similar mass spectra, only the A30P mutant spectra are presented in Fig. 1. The
negative ion mass spectrum of the A30P mutant at pH 7.5 shows a broad distribution of charge
states ranging from −6 to −17, centered at −13. There is also a second smaller distribution of
half integer charge states (i.e. z/n = −15/2, −17/2… where z is the ion charge and n is the
oligomer order). At pH 2.5 the charge state distribution is shifted to lower charge states,
centered at −9, significantly narrowed, ranging only from −6 to −11, and the half integer charge
states no longer appear. This shift in charge state distribution is consistent with a protein that
is natively unfolded at pH 7.5 and partially folded at pH 2.5.25–28 In addition, the smaller
aggregates appear to have further aggregated to larger oligomers out of the mass range of our
quadrupole. These same trends are observed for the A53T mutant as well as WT α-syn.29
Arrival Time Distributions (ATDs) were obtained, and cross sections measured, for charge
states −6 and above for each sample. For charge states that were present at both pH 2.5 and
pH 7.5, ATDs and cross sections are comparable at each pH, the one exception being the −10
charge state for the two mutants. The A30P mutant −10 ATD contains a single peak at pH 2.5
but has two features at pH 7.5 while the A53T mutant −10 ATD contains two features at pH
2.5 and only a single peak at pH 7.5. It is important to note however that the overall peak width
and average cross section of this charge state for both mutants is the same at each pH. In
addition, multiple features are present in the ATDs for the low charge states −6 through −8 for
WT α-syn and the A53T mutant, and −6 through −9 for the A30P mutant.
The mass spectrum at pH 7.5 in Fig. 1 contains a charge state distribution composed of half
integer charge states which arises from the presence of multiply charged oligomers. Therefore,
a percentage of each monomer peak in the mass spectrum may be composed of multiply charged
oligomer (a monomer with 7 charges and a dimer with 14 charges have the same z/n value)
which may contribute to the ATD for that charge state. However, data was taken under a variety
of solution conditions (data not shown) some of which led to mass spectra in which no evidence
for multiply charged oligomers was present. In all cases, the overall ATD peak width for a
particular whole number charge state and the structures in the ATD are conserved, i.e. the
ATDs for the −6 charge state look essentially the same regardless of how much multiply
charged oligomer is observable in the mass spectrum. Since the ATDs for samples where
oligomers were present in the mass spectrum appear qualitatively the same as ATDs for samples
with no multiply charged oligomers present in the mass spectrum, it appears that we are
primarily observing the ATDs for monomeric forms of the protein for whole integer z/n peaks.
The ATDs presented in Fig. 2 and Fig 3 were taken at pH 2.5 where no dimer peaks are observed
under any source conditions so these are unambiguously pure monomer ATDs.
For each of the ATDs exhibiting multiple features, the dominant feature varies with injection
energy, as shown in Fig. 2 for the WT α-syn −7 ATD at pH 2.5. At low injection energy (30
eV), the ATD has a broad distribution centered near 870 µs. The broadness of the distribution
implies that there are several conformers present, and a dominant family of structures with an
average cross section of 1730 Å2. When the injection energy is increased (50 eV), the ATD is
shifted toward later arrival times. At high injection energy (100 eV), a dominant family of
structures is seen again, this time with an average cross section of 2078 Å2. These results
suggest the more compact structures are present in solution, and we observe these at low
injection energies, but as the injection energy is increased they are annealed to a family of more
extended structures preferred in the solvent-free state.
At higher charge states the ATDs all become much narrower and contain a single feature. Fig.
3 shows a comparison of ATDs taken at pH 2.5 for several charge states of WT α-syn and both
the A30P and A53T mutants. ATDs for WT α-syn and the A53T mutant at each charge state
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are very similar. For the −7 and −8 charge states, ATDs for WT α-syn and the A53T mutant
are much broader than the corresponding ATDs for the A30P mutant. For these charge states
the A30P mutant populates more extended families of structures than WT α-syn and the A53T
mutant. ATDs for the −9 charge state for each protein have similar widths, although the A30P
mutant ATD has multiple features. However, the broadness of the WT α-syn and A53T mutant
ATDs could easily contain multiple unresolved features. After the −9 charge state, all three
proteins have significantly narrowed distributions and for charge states −11 and above they all
contain a single well defined peak as exemplified by the −12 charge state.
Cross sections measured for the monomer charge states of all three samples are summarized
in Fig. 4. Since pH does not appear to affect the cross sections, average cross sections across
both pHs are plotted. There is a family of relatively compact structures dominant in low charge
states and one of more extended structures dominant in high charge states. For WT α-syn and
the A53T mutant the compact family of structures is present in charge states −6 through −8.
For the A30P mutant however, this compact family is seen only in the −6 charge state. The
extended family of structures in all three proteins increases in cross section with charge state
due to Coulomb repulsion between the charges leading to more open structures and larger cross
sections as z/n increases.
When spermine was added to the protein solutions a stable spray could not be obtained from
acidic solutions, but good data were obtained for neutral solutions. A mass spectrum of the
pure A53T mutant is given in Fig. 5a for reference. As shown in Fig. 5b, at an intermediate
injection energy of 50ev, when spermine is added a bimodal distribution of charge states is
observed with −9 being locally dominant, but −6 clearly being the dominant charge state
overall. This represents a huge shift in the dominant charge state, which ranges from −11
through −13 for the neutral solutions without spermine, where the −6 peak is barely visible.
Satellite peaks are clearly visible at higher mass representing α-syn/spermine complexes and
the dimer peaks evident at half integral z/n values in Fig. 5a have disappeared, most likely due
to increased oligomerization. One very interesting thing about this spectrum is that not only is
the [α-syn + spermine]−6 peak the largest of the complex peaks, but [α-syn]−6 is the largest
unbound charge state as well. At a high injection energy of 100ev, Fig. 5c, the α-syn/spermine
complex peaks are no longer observed, and large unresolved peaks from dissociation of higher
order oligomers are present. In addition, highly charged monomers are observed that are only
weakly present in Fig. 5b, presumably from monomer dissociation from the large oligomers.
30,31
ATDs for the −6 charge state of the A53T mutant from solutions both with and without
spermine at an injection energy of 50eV are given in Fig. 6. All three ATDs are complex with
families of conformations having cross sections near 1440Å2 and 1780 Å2. The relative
intensities of the peaks in the ATDs of the free protein in solution and the unbound protein in
the complex solution are very similar, while the peak corresponding to the more compact
conformational family dominates the ATD of the α-syn/spermine complex. Of interest is the
fact that no new conformational families were observed, only a strong shift to more compact
structures. WT α-syn and the A30P mutant gave similar results. It is also important to notice
that no dimers are present in the mass spectrum in Fig. 5b that yielded the ATDs in Fig. 6b and
Fig. 6c. Hence, these ATDs are due to pure monomer. The ATD in Fig 6a is very similar to
the one in Fig. 6b, strongly supporting the fact it is also due to monomer.
Discussion
As shown in Fig. 1 the A30P mutant has a much narrower and lower charge state distribution
at pH 2.5 than at pH 7.5. This same behavior is observed for the A53T mutant and WT α-syn,
29 as well. The shift in charge state distribution alone is evidence that the protein is more
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compact under acidic compared to physiologic conditions,25–28 but further evidence comes
from looking beyond charge state distribution and comparing the cross sections of each charge
state. Since low charge states have smaller cross sections, and more of the protein exists in low
charge states at pH 2.5 than at pH 7.5, this implies that the protein is more compact at the lower
pH. A number of factors are known to trigger aggregation in WT α-syn by inducing a partially
folded state, including low pH.7
ATDs for WT α-syn and the A53T mutant show evidence of a highly compact, partially folded
family of structures for net charges −6, −7 and −8. The A30P mutant ATDs however only
demonstrate this partially folded state at a net charge of −6. As can be seen in Fig. 4 the cross
sections of the more extended families of structures for the −7 and −8 charge states are very
similar for all three proteins, but the smallest structures observed for the A30P mutant are 30–
40% larger than the smallest structures observed for WT α-syn and the A53T mutant.
Fluorescence energy-transfer (FET) kinetics experiments by Lee et al32 have shown that the
distances between two donor/acceptor pairs in the vicinity of residue 30 were increased for the
A30P mutant relative to WT α-syn in neutral solutions, while in acidic solutions the distances
decreased. Since our results show an increase in cross section at both neutral and acidic pHs,
the mutation must be inducing a large scale structural change in the protein that outweighs this
localized compaction in acidic conditions. The single residue mutation, substitution of a proline
in place of an alanine, causes a significant increase in the overall size of the compact structures
of α-syn and most likely prevents the formation of the partially folded intermediate with a net
charge of more than −6. This dramatic dependence of foldedness on charge may account for
some of the inconclusive results on aggregation rates of the A30P mutant compared to WT α-
syn.4,11–14 The A30P mutation is known to disrupt a region of residual helical structure found
near the N-terminus in the WT protein,33 and this may be a contributing factor for the increase
in cross sections that we observe.
Another factor known to increase α-syn aggregation is binding with cationic species such as
metal ions34–38 and polyamines.18,19,21 Interestingly, while metal ion binding is thought to
increase aggregation by facilitating collapse into a partially folded state,37 binding of
polyamines appears to trigger aggregation without inducing significant changes in secondary
structure.18,19,21 One of the most effective polyamines in this respect is spermine, a naturally
occurring polyamine that binds to α-syn via a specific interaction with the C-terminus and
increases the kinetic efficiency of aggregation by 105.21 Recent NMR studies have shown that
although spermine binds near the C-terminus, structural changes may occur near the N-
terminus, particularly affecting glycine and threonine residues in the region aa22–93.21,39 In
spite of this interaction, data collected for the A53T mutant, which introduces a threonine
residue in the aa22–93 region, were the same as that for WT α-syn and the A30P mutant.
Addition of spermine to all three protein samples results in a dominant charge state of −6 in
each mass spectrum. In solution at pH 7.5, the protein exists in an equilibrium of conformations,
but being natively unfolded at this pH, the majority of α-syn is expected to have a net charge
between −9 and −10. A plot of net charge on α-syn vs. pH, as estimated from the protein
sequence and amino acid pKa values40, is given in Fig. 7. At pH 7.5 spermine, shown
schematically in Fig. 5b, exists as a polycation with net charge +4 so it is reasonable to predict
that in solution the net charge of the protein/cation complex is −6. The dominance of the −6
charge state in the mass spectrum of the α-syn/spermine mixture (Fig. 5b) and the presence of
a bimodal charge state distribution, rather than a shift of the original charge state distribution
by four charges, shows that spermine forms a compact folded complex with α-syn in solution,
reducing the number of sites available for deprotonation during electrospray. Looking at the
ATDs for this charge state, we do not see any new conformational families but we do see a
significant shift in intensity to favor the more compact structures in the complex as compared
to the unbound protein. However, it is important to recall that spermine is binding to a protein
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with a net charge of −10 in solution (average cross section near 2600Å2), reducing the charge
to −6 and reducing the cross section of most of the protein to 1430Å2, a size reduction of nearly
a factor of two. Some very small fraction of uncomplexed α-syn exists in the −6 charge state
in pure α-syn solutions under physiological conditions and a fraction of that small fraction is
in the compact conformation. However, when spermine is added α-syn/spermine complexation
results, yielding nearly 100% compact α-syn.
The fact that not only is the −6 charge state dominant in the α-syn/spermine complex charge
state distribution but also in the free α-syn protein distribution strongly suggests that in solution
an [α-syn + spermine]−6 complex is dominantly formed, which then partially dissociates to
form [α-syn]−6 and neutral spermine upon being sprayed, dehydrated, and traversing the IMS-
MS instrument. Since the [α-syn]−6 ATD in the α-syn/spermine mixture closely resembles the
ATD from the pure α-syn sample, some refolding/unfolding must occur upon spermine
dissociation. The 1430Å2 structure is most likely a “solution” structure, while the 1780 Å2
structure is a “solvent-free” structure which results from unfolding once spermine dissociates.
This process is shown schematically in Fig. 8. (This interpretation is also consistent with the
1730Å2 structure for [α-syn]−7 unfolding to a “solvent-free” structure at 2078Å2 as injection
energy is increased (Fig. 2)). Exactly where the dissociation of the α-syn/spermine complex
occurs is not apparent, but the lower intensity of the complex peak compared to the unbound
protein peak implies that it does occur somewhere, since it has previously been shown41 that
a significant amount of spermine bound protein can be detected by ESI-MS. Our
instrumentation23 is very different from most commercial mass spectrometers in that it
incorporates an ion funnel to capture, desolvate, and transport the ions coming out of the
capillary, and a drift cell filled with ~5 torr of helium buffer gas. A significant amount of energy
must be imparted to the ions in order to inject them from vacuum into the drift cell, and this
step may account for dissociation of the complex. In fact, as injection energy is increased, the
α-syn/spermine complex is essentially completely dissociated (see Fig. 5c).
It has been shown that the rate of fibrillization of α-syn in vitro is significantly increased by
the presence of certain metal ions34–38 most likely due to the metals’ ability to mask
electrostatic repulsions and facilitate collapse into a partially folded intermediate.7,42 We
propose that a similar process, illustrated in Fig. 9, takes place upon the addition of spermine.
In the protein solution without spermine, a range of conformations exists in equilibrium, a
small fraction of which are compact while the majority are extended. Once spermine is added,
most of the extended conformations are rearranged to become more compact due to the
dramatic charge reduction. This α-syn/spermine complex doesn’t appear to result in any new
structures as the cross sections are very similar to the compact form of the free −6 α-syn protein.
We hypothesize that it is these more compact conformations that aggregate and go on to form
fibrils. In the solution with no spermine, there are very few of these compact conformations
so aggregation will proceed slowly. In the presence of spermine however, the higher proportion
of compact conformations induces faster aggregation possibly accounting for the 105 increase
in aggregation efficiency.21
The mechanism of α-syn aggregation in the presence of spermine is still not well understood
and models of the process are varied. Electron capture dissociation41 (ECD), and NMR39
studies have proposed that spermine binding to α-syn leads to larger, more extended structures.
It has been suggested that charge shielding resulting from spermine binding to the protein
reduces intramolecular electrostatic interactions between the C-terminal region and central/N-
terminal regions of α-syn, reducing the protein’s overall compactness and forming an open
structure more favorable for self-assembly. It has also been proposed19,43 that the increased
rate of α-syn aggregation in the presence of spermine can be accounted for by the binding of
spermine causing a reduction in electrostatic repulsion between molecules undergoing self-
assembly. Alternatively, it has been suggested that the multivalent polyamine may act as a
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bridge between protein monomers.18,43 Like most natively unfolded proteins, WT α-syn and
its A30P and A53T mutants are characterized by low hydrophobicity and high net charge.44
Several independent studies have shown that the aggregation of amyloidogenic proteins/
peptides is very much dependent on net charge, with a lower net charge leading to faster
aggregation.45–47 Reduction in net charge leading to a partially folded intermediate has been
proposed as the mechanism by which cationic metal binding7,42 and low pH7 increase α-syn
aggregation. In light of the dramatic compaction spermine induces in α-syn as shown here, it
is reasonable to propose a similar effect from polyamines.
It is highly likely that protein aggregation is occurring in our experiments, as evidenced by the
significant overall loss of signal in the α-syn/spermine solutions relative to the pure α-syn
solutions (see enhanced noise level in Fig. 5b and Fig. 5c relative to Fig. 5a). Dimer peaks
evident in spectra from the pure α-syn solutions (Fig. 5a) are not present in spectra from α-syn/
spermine solutions (Fig. 5b), presumably because they have gone on to form higher order
oligomers that are out of the mass range of our instrument. Increasing the injection energy
causes some of the higher order oligomers to dissociate, creating observable oligomers within
our mass range. These oligomers appear as large unresolved peaks in the mass spectrum shown
in Fig. 5c.
It is important to consider how the solvent-free results presented here relate to solution
structures. As Loo48 has pointed out, there are several noncovalently bound protein ligand
complexes in which the observed gas phase stoichiometry is in agreement with that expected
in the solution. There have also been numerous studies in which elements of solution phase
structure are preserved in the gas phase. Relevant examples include, but are not limited to,
large protein assemblies such as GroEL-substrate complexes49 and the 11-member ring
complex formed by the trp RNA binding attenuation protein (TRAP),50 globular monomeric
proteins including cytochrome c,51 and smaller biomolecules such as the Alzheimer’s peptide
amyloid-beta.52 Our injection energy results indicate that at low injection energies compact
structures are observed while at higher injection energies these tend to unfold, presumably to
more favorable solvent-free structures. Hence, we are confident that the current results reflect
solution properties of the system.
Conclusions
• Highly compact families of structures are present for WT α-syn and its A53T mutant
with net charges of −6, −7 and −8. The A30P mutant only exists in a highly compact
form with net charge −6, possibly accounting for its inconsistent aggregation
behavior.
• All three proteins behave the same in the presence of spermine.
• Spermine effectively binds to an extended conformation and rearranges it to a much
more compact form by lowering the net charge from −10 to −6.
• Mass spectral results suggest spermine complexation may induce oligomerization of
α-syn.
Abbreviations
α-syn, α-synuclein; PD, Parkinson’s Disease; ATD, Arrival Time Distribution; WT, Wild
Type.
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Fig. 1.
The negative ion mass spectrum of A30P α-syn shows a broad distribution at pH 7.5 which is
shifted to lower charge states and significantly narrowed at pH 2.5.
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Fig. 2.
The ATD for the −7 charge state of WT α-syn at pH 2.5 demonstrates how the dominant features
of low charge state ATDs vary with injection energy.
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Fig. 3.
ATDs of several charge states taken at an injection energy of 50eV at pH 2.5. For charge states
−7 and −8 the A30P mutant ATDs are much narrower than the WT and A53T mutant ATDs.
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Fig. 4.
Cross section vs. charge state for WT α-syn and its A53T and A30P mutants. Two families of
structures are clearly evident, one dominant in low charge states and one dominant in high
charge states.
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Fig. 5.
Negative ion mass spectrum of pure A53T α-syn taken at pH 7.5 with an intermediate injection
energy of 50eV (a). Upon addition of spermine under the same conditions (b) the charge state
distribution is dramatically shifted and α-syn/spermine complex peaks are observed. At a high
injection energy of 100eV (c), the complex peaks are no longer easily observed, and large
unresolved peaks from dissociation of higher order oligomers are present.
Grabenauer et al. Page 15
J Phys Chem B. Author manuscript; available in PMC 2009 September 4.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 6.
ATDs of the A53T α-syn mutant showing the presence of similar conformational families in
the free protein in solution (a), the unbound protein in the complex solution (b), and the protein-
spermine complex (c). A significantly greater percentage of the population is in the compact
form in the complex as compared to the unbound protein.
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Fig. 7.
Plot of net charge on α-syn vs. pH, as estimated from its amino acid composition.
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Fig. 8.
Schematic representation of spermine binding to α-syn, rearranging the protein, then
dissociating as a neutral molecule.
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Fig. 9.
Illustration of a hypothetical mechanism for the accelerated aggregation of α-syn due to
spermine binding.
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